Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:45 PM
Ignite Modification Date:
2025-12-24 @ 6:45 PM
NCT ID:
NCT04428957
Eligibility Criteria:
Inclusion Criteria:
* Newly diagnosed interstitial lung disease with a small component of fibrous changes;
* Indications for systemic glucocorticoid therapy +/- immunosuppressant;
* 18 years and older
* Informed consent to participate in the study;
* Effective contraception;
* Result of the Mini Mental test ensuring the possibility of efficient operation of monitoring devices;
* Completed training in the operation of telemedicine equipment.
Exclusion Criteria:
* Evidence of irreversible interstitial fibrotic changes in lung HRCT;
* Pattern of definite or probable usual interstitial pneumonia (UIP) in the HRCT examination;
* Contraindications to glucocorticoid and immunosuppressive therapy (azathioprine or mycophenolate mofetil or cyclophosphamide or cyclosporine);
* Pregnancy and breast-feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04428957
Study Brief:
Protocol Section:
NCT04428957